IWIsabella Nymann Westensee

Isabella Nymann Westensee

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Isabella Nymann Westensee has a total of 45 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Transmembrane Condensation in Albumin‐Loaded Giant Vesicles Induced by an Intrinsically Disordered Protein

    by Paula De Dios Andres, Ankush Garg, Ramy Alam, Isabella N. Westensee, Magnus Kjaergaard, Brigitte Städler

    The interplay between biomolecular condensates and cellular membranes is central to understanding dynamic intracellular organization and membrane repair. Here, we present a minimal synthetic system to examine how membrane composition and curvature govern condensate–membrane interactions within this model platform. We demonstrate that the exposure of either lipid or polymer–lipid hybrid giant vesicles with encapsulated bovine serum albumin to a resilin‐inspired intrinsically disordered protein (IDP), which undergoes liquid–liquid phase separation, results in in situ formation of transmembrane condensates. This observation of cargo‐triggered condensation across giant vesicle membranes directly links encapsulated protein crowding to condensate nucleation and insertion. The condensation morphology was tunable by vesicle size and membrane elasticity where smaller vesicles and stiffer hybrid membranes favored transmembrane condensation, whereas larger or softer membranes promoted membrane wetting and deformation. Condensate formation locally reorganized lipids and facilitated leaflet coupling without compromising overall membrane integrity or cargo retention. This mechanistic understanding offers a unique opportunity to gain insight into the complex cell biological process of membrane repair using a minimal system.

  • Open Access

    Building a Synthetic Cell Together

    by S. Giaveri, Z. Abil, S. Kohyama, M. Fu, A. Levrier, K. Adamala, W. Chinantuya, C. Dekker, N. Deng, J. Fredens, et al.

    Synthetic cells (SynCells) are artificial constructs designed to mimic cellular functions, offering insights into fundamental biology, as well as promising impact in the fields of medicine, biotechnology, and bioengineering. Achieving a functional SynCell from the bottom up, i.e. by assembling it from molecular components, requires a global collaboration to overcome the many challenges of engineering and assembling life-like modules while addressing biosafety, equity, and ethical concerns in order to guide responsible innovation. Here, we highlight major scientific hurdles, such as the integration of functional modules by ensuring compatibility across diverse synthetic subsystems, and we propose strategies to advance the field.


  • Open Access

    Engineered Lipids for Intracellular Reactive Oxygen Species Scavenging in Steatotic Hepatocytes

    by Isabella N. Westensee, Paula de Dios Andres, Edit Brodszkij, Pierre‐Louis Descours, Diego Perez‐Rodriguez, Antonella Spinazzola, Rajeshwar Prosad Mookerjee, Brigitte Städler

    Intracellular reactive oxygen species (ROS) in steatotic cells pose a problem due to their potential to cause oxidative stress and cellular damage. Delivering engineered phospholipids to intracellular lipid droplets in steatotic hepatic cells, using the cell's inherent intracellular lipid transport mechanisms are investigated. Initially, it is shown that tail‐labeled fluorescent lipids assembled into liposomes are able to be transported to intracellular lipid droplets in steatotic HepG2 cells and HHL‐5 cells. Further, an antioxidant, an EUK salen–manganese derivative, which has superoxide dismutase‐like and catalase‐like activity, is covalently conjugated to the tail of a phospholipid and formulated as liposomes for administration. Steatotic HepG2 cells and HHL‐5 cells incubated with these antioxidant liposomes have lower intracellular ROS levels compared to untreated controls and non‐covalently formulated antioxidants. This first proof‐of‐concept study illustrates an alternative strategy to equip native organelles in mammalian cells with engineered enzyme activity.


  • Open Access

    From Single‐Compartment Artificial Cells to Tissue‐Like Materials

    by Isabella N. Westensee, Paula de Dios Andres, Brigitte Städler

    Designing and assembling artificial cells (ACs) is a core direction in bottom‐up synthetic biology. Here, the advancements in the past 3 years in engineering ACs with focus on compartmentalization and surface modifications with the aim for their integration in semi‐synthetic tissue are outlined. Compartmentalization in vesicles, coacervates and hydrogels are discussed for encapsulated catalysis or cytoskeleton formation including the use of components of mammalian cells to increase the ACs’ complexity. Following on, the surface modification of the ACs is reviewed due to its relevance when integration of ACs with mammalian cells into semi‐synthetic tissue is the goal. Finally, the interaction of ACs and mammalian cells for cellular communication or the fabrication of semi‐synthetic tissue toward therapeutic opportunities is outlined, before a short perspective is provided.


  • Open Access

    Artificial Cells and HepG2 Cells in 3D‐Bioprinted Arrangements

    by Isabella N. Westensee, Lars J.M.M. Paffen, Stefan Pendlmayr, Paula De Dios Andres, Miguel A. Ramos Docampo, Brigitte Städler

    Artificial cells are engineered units with cell‐like functions for different purposes including acting as supportive elements for mammalian cells. Artificial cells with minimal liver‐like function are made of alginate and equipped with metalloporphyrins that mimic the enzyme activity of a member of the cytochrome P450 family namely CYP1A2. The artificial cells are employed to enhance the dealkylation activity within 3D bioprinted structures composed of HepG2 cells and these artificial cells. This enhancement is monitored through the conversion of resorufin ethyl ether to resorufin. HepG2 cell aggregates are 3D bioprinted using an alginate/gelatin methacryloyl ink, resulting in the successful proliferation of the HepG2 cells. The composite ink made of an alginate/gelatin liquid phase with an increasing amount of artificial cells is characterized. The CYP1A2‐like activity of artificial cells is preserved over at least 35 days, where 6 nM resorufin is produced in 8 h. Composite inks made of artificial cells and HepG2 cell aggregates in a liquid phase are used for 3D bioprinting. The HepG2 cells proliferate over 35 days, and the structure has boosted CYP1A2 activity. The integration of artificial cells and their living counterparts into larger 3D semi‐synthetic tissues is a step towards exploring bottom‐up synthetic biology in tissue engineering.


  • Open Access

    Astrocytes in Paper Chips and Their Interaction with Hybrid Vesicles

    by Cathrine Abild Meyer, Paula De Dios Andres, Edit Brodszkij, Isabella N. Westensee, Joseph Lyons, Sandra H. Vaz, Brigitte Städler

    The role of astrocytes in brain function has received increased attention lately due to their critical role in brain development and function under physiological and pathophysiological conditions. However, the biological evaluation of soft material nanoparticles in astrocytes remains unexplored. Here, the interaction of crosslinked hybrid vesicles (HVs) and either C8‐D1A astrocytes or primary astrocytes cultured in polystyrene tissue culture or floatable paper‐based chips is investigated. The amphiphilic block copolymer poly(cholesteryl methacrylate)‐block‐poly(2‐carboxyethyl acrylate) (P1) and 1,2‐dioleoyl‐sn‐glycero‐3‐phosphoethanolamine lipids are used for the assembly of HVs with crosslinked membranes. The assemblies show no short‐term toxicity towards the C8‐D1A astrocytes and the primary astrocytes, and both cell types internalize the HVs when cultured in 2D cell culture. Further, it is demonstrated that both the C8‐D1A astrocytes and the primary astrocytes could mature in paper‐based chips with preserved calcium signaling and glial fibrillary acidic protein expression. Last, it is confirmed that both types of astrocytes could internalize the HVs when cultured in paper‐based chips. These findings lay out a fundamental understanding of the interaction between soft material nanoparticles and astrocytes, even when primary astrocytes are cultured in paper‐based chips offering a 3D environment.


  • Open Access

    Polymer Micelles vs Polymer–Lipid Hybrid Vesicles: A Comparison Using RAW 264.7 Cells

    by Carina Ade, Xiaomin Qian, Edit Brodszkij, Paula De Dios Andres, Järvi Spanjers, Isabella N. Westensee, Brigitte Städler

    Bottom-up synthetic biology aims to integrate artificial moieties with living cells and tissues. Here, two types of structural scaffolds for artificial organelles were compared in terms of their ability to interact with macrophage-like murine RAW 264.7 cells. The amphiphilic block copolymer poly(cholesteryl methacrylate)-block-poly(2-carboxyethyl acrylate) was used to assemble micelles and polymer–lipid hybrid vesicles together with 1,2-dioleoyl-sn-glycero-3-phosphocholine or 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE) lipids in the latter case. In addition, the pH-sensitive fusogenic peptide GALA was conjugated to the carriers to improve their lysosomal escape ability. All assemblies had low short-term toxicity toward macrophage-like murine RAW 264.7 cells, and the cells internalized both the micelles and hybrid vesicles within 24 h. Assemblies containing DOPE lipids or GALA in their building blocks could escape the lysosomes. However, the intracellular retention of the building blocks was only a few hours in all the cases. Taken together, the provided comparison between two types of potential scaffolds for artificial organelles lays out the fundamental understanding required to advance soft material-based assemblies as intracellular nanoreactors.


  • Open Access

    Enzyme Mimic Facilitated Artificial Cell to Mammalian Cell Signal Transfer

    by Xiaomin Qian, Isabella Nymann Westensee, Catarina Cavalheiro Fernandes, Brigitte Städler

    Catalyzing biochemical reactions with enzymes and communicating with neighboring cells via chemical signaling are two fundamental cellular features that play a critical role in maintaining the homeostasis of organisms. Herein, we present an artificial enzyme (AE) facilitated signal transfer between artificial cells (ACs) and mammalian HepG2 cells. We synthesize metalloporphyrins (MPs) based AEs that mimic cytochrome P450 enzymes (CYPs) to catalyze a dealkylation and a hydroxylation reaction, exemplified by the conversion of resorufin ethyl ether (REE) to resorufin and coumarin (COU) to 7‐hydroxycoumarin (7‐HC), respectively. The AEs are immobilized in hydrogels to produce ACs that generate the two diffusive fluorophores, which can diffuse into HepG2 cells and result in dual intracellular emissions. This work highlights the use of AEs to promote AC to mammalian signal transfer, which opens up new opportunities for integrating the synthetic and living world with a bottom‐up strategy.


  • Open Access

    Enzyme Mimic Facilitated Artificial Cell to Mammalian Cell Signal Transfer

    by Xiaomin Qian, Isabella Nymann Westensee, Catarina Cavalheiro Fernandes, Brigitte Städler

    Catalyzing biochemical reactions with enzymes and communicating with neighboring cells via chemical signaling are two fundamental cellular features that play a critical role in maintaining the homeostasis of organisms. Herein, we present an artificial enzyme (AE) facilitated signal transfer between artificial cells (ACs) and mammalian HepG2 cells. We synthesize metalloporphyrins (MPs) based AEs that mimic cytochrome P450 enzymes (CYPs) to catalyze a dealkylation and a hydroxylation reaction, exemplified by the conversion of resorufin ethyl ether (REE) to resorufin and coumarin (COU) to 7‐hydroxycoumarin (7‐HC), respectively. The AEs are immobilized in hydrogels to produce ACs that generate the two diffusive fluorophores, which can diffuse into HepG2 cells and result in dual intracellular emissions. This work highlights the use of AEs to promote AC to mammalian signal transfer, which opens up new opportunities for integrating the synthetic and living world with a bottom‐up strategy.


  • Mitochondria Encapsulation in Hydrogel‐Based Artificial Cells as ATP Producing Subunits

    by Isabella Nymann Westensee, Edit Brodszkij, Xiaomin Qian, Thaís Floriano Marcelino, Konstantinos Lefkimmiatis, Brigitte Städler

    Artificial cells (ACs) aim to mimic selected structural and functional features of mammalian cells. In this context, energy generation is an important challenge to be addressed when self‐sustained systems are desired. Here, mitochondria isolated from HepG2 cells are employed as natural subunits that facilitate chemically driven adenosine triphosphate (ATP) synthesis. The successful mitochondria isolation is confirmed by monitoring the preserved inner membrane potential, the respiration, and the ATP production ability. The encapsulation of the isolated mitochondria in gelatin‐based hydrogels results in similar initial ATP production compared to mitochondria in solution with a sustained ATP production over 24 h. Furthermore, luciferase is coencapsulated with the mitochondria in gelatin‐based particles to create ACs and employ the in situ produced ATP to drive the catalytic conversion of d‐luciferin. The coencapsulation of luciferase‐loaded liposomes with mitochondria in gelatin‐based hydrogels is additionally explored where the encapsulation of mitochondria and liposomes resulted in clustering effects that are likely contributing to the functional performance of the active entities. Taken together, mitochondria show potential in cell mimicry to facilitate energy‐dependent processes.